Avalo Therapeutics, Inc. (AVTX) has 12 identified peers for comparison in the Healthcare sector. Peers include ACLX, ACRV, ALXO, ALZN, ANAB, ANEB and others.
AVTX has a market capitalization of $156.99M, compared to an average peer market cap of $1.17B. AVTX is notably smaller than its average peer.